Updated:
SeedToB Capital
SeedtoB Capital are value-add investors in Seed and Series A healthcare AI companies. As founders of Jvion, they were early innovators in healthcare AI and use...
SeedToB Capital
SeedtoB Capital are value-add investors in Seed and Series A healthcare AI companies. As founders of Jvion, they were early innovators in healthcare AI and use their network and tactical expertise to help founders reach Series B. They invest where advanced technology and clinical expertise intersect to drive impact for payers, providers, and patients.
General information
Firm type
Private Equity
Year founded
2020
Location
Region
North America
Country
United States
City
Suwanee
Corporate office
Suwanee, GA, United States
Additional offices
Nashville, TN, United States
Principals
Shantanu Nigam
Co-Founder & Managing Partner
Ritesh Sharma
Co-Founder & Managing Partner
Vikrant Vaid
Fund Operations & Investment Due Diligence
Maya Menon
Investor & Growth Strategy
Eller Kelliher
Venture Investor
Sector focus
Frequently asked questions
Who runs investment decisions at SeedToB Capital?
Co-founders Shantanu Nigam and Ritesh Sharma lead investment decisions as Managing Partners. Both are former operators — Nigam was CEO and Sharma was COO of Jvion, the clinical AI platform they built and sold — giving them direct tactical authority over the firm’s healthcare-focused thesis.
How does SeedToB source proprietary deal flow?
Deal flow runs largely through the founders’ decades-old relationships with hospital systems, payers, and digital health investors cultivated during their Jvion years. Portfolio founder Eller Kelliher, based in Nashville and previously Managing Director of Jumpstart Foundry, provides an additional sourcing channel into one of the densest healthcare innovation hubs in the US.
Does SeedToB participate in fund commitments or only direct deals?
The firm highlights only direct investments in Seed and Series A healthcare technology companies. There is no public indication it commits capital to external funds as a limited partner.
What investment stages does SeedToB typically target?
SeedToB targets Seed and Series A rounds, with initial checks of $500,000 to $1.5 million. The firm explicitly structures its support to help startups reach Series B, and states an intention to provide follow-on capital through the early stage.
How does SeedToB’s Jvion exit inform its current posture?
Nigam and Sharma took Jvion from founding through a 2019 private equity acquisition. That pattern — building a clinically validated AI platform, scaling it to industry leadership as measured by Blackbook and KLAS (2018), and exiting — is the operational model they now replicate to help portfolio founders chart the most efficient path to Series B.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: